Pulmex® baby (Ointment) Instructions for Use
Marketing Authorization Holder
Novartis Consumer Health S.A. (Switzerland)
ATC Code
R05CA10 (Expectorants in combination)
Active Substances
Rosemary oil (BP British Pharmacopoeia)
Eucalyptus oil (BP British Pharmacopoeia)
Peru balsam (BP British Pharmacopoeia)
Dosage Form
| Pulmex® baby | Ointment for external use 50 mg+50 mg+60 mg/1 g: tube 20 g |
Dosage Form, Packaging, and Composition
Ointment for external use white color, homogeneous, with smell of essential oils.
| 1 g | |
| Rosemary oil | 50 mg |
| Eucalyptus leaves oil | 50 mg |
| Peru balsam | 60 mg |
Auxiliary substances : carbomer 974R – 1.2%, sodium hydroxide solution 30% – 0.92%, polysorbate 20 – 5%, purified water – about 76.88%.
20 g – aluminum tubes (1) – cardboard packs.
Clinical-Pharmacological Group
Preparation with antimicrobial, anti-inflammatory and expectorant action for external use in respiratory tract diseases
Pharmacotherapeutic Group
Herbal remedy
Indications
- Pulmex® baby ointment is indicated as an adjunctive therapy for the symptomatic relief of upper respiratory tract congestion associated with the common cold and other uncomplicated respiratory infections.
- It is used to help alleviate symptoms such as cough and nasal congestion in infants and young children.
- The preparation’s action is based on the local effects of its essential oils, which provide a soothing sensation and help to ease breathing when applied topically to the chest and back.
Contraindications
- Hypersensitivity to any of the active substances (rosemary oil, eucalyptus oil, Peru balsam) or to any of the excipients.
- Patients with a known history of allergic contact dermatitis, especially to balsams or essential oils.
- Do not apply to damaged skin, such as open wounds, burns, or eczematous skin, as this increases systemic absorption and the risk of irritation.
- Avoid use in children with a history of bronchospasm, such as in asthma or bronchial hyperreactivity, as inhalation of vaporized essential oils may trigger bronchoconstriction.
- Contraindicated in cases of whooping cough (pertussis) or pseudo-croup.
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
For external use only. Pulmex® baby ointment is intended for topical application on the skin of the chest and back. It must not be applied to the face, nostrils, or mucous membranes.
The recommended dosage for infants and children is application two to three times daily. A thin layer of the ointment should be rubbed gently onto the skin of the chest and upper back. For enhanced effect, especially at night, the area can be covered with a warm, dry cloth. The duration of use should be in accordance with the physician’s recommendations, typically for the duration of acute symptoms.
Critical Administration Instructions: Always wash hands before and after application. Avoid contact with eyes. Do not use with tight-fitting occlusive dressings that may promote excessive absorption. If symptoms persist after one week of use, or if the condition worsens, a physician should be consulted.
Adverse Reactions
Like all medicines, Pulmex® baby ointment can cause adverse reactions, although not everybody gets them. Due to the topical route of administration, adverse reactions are primarily localized to the site of application.
Common (May affect up to 1 in 10 people): Mild, transient skin reactions at the application site, such as redness (erythema), a warming sensation, or mild pruritus (itching). These reactions typically subside with continued use.
Uncommon (May affect up to 1 in 100 people): More pronounced local skin reactions including contact dermatitis, skin rash, urticaria (hives), or a burning sensation. In very rare cases, systemic allergic reactions are possible, particularly if the product is applied to large areas of damaged skin, leading to increased absorption.
Special Populations: In children with very sensitive skin or pre-existing skin conditions, the risk of local adverse reactions may be increased. Discontinue use immediately if signs of a severe skin reaction or systemic allergic response (such as dyspnea or wheezing) occur and seek medical attention.
Drug Interactions
Formal studies of drug interactions with Pulmex® baby ointment have not been conducted. However, due to the pharmacological properties of the active ingredients, potential interactions should be considered.
The percutaneous absorption of essential oils is generally low, but may be increased if applied to large body surface areas or damaged skin. There is a theoretical potential for interaction with other centrally acting drugs, as some components like camphor (though not present in this formulation) and eucalyptol are known to have neurological effects.
Concurrent use with other topical products applied to the same area (e.g., other ointments, creams, or medicated patches) should be avoided, as this may alter the absorption of either product or increase the potential for skin irritation. Patients using medications for seizure disorders or other neurological conditions should use this product with caution and under medical supervision.
Overdose
Overdose due to topical application is unlikely. However, accidental ingestion of the ointment is a medical emergency, especially in children, and requires immediate medical attention.
Symptoms of Ingestion: Ingestion of even small amounts can lead to gastrointestinal irritation, nausea, vomiting, and abdominal pain. Larger ingestions may result in more severe symptoms, including central nervous system effects such as dizziness, confusion, and seizures. Essential oils can be highly toxic when ingested and may cause aspiration pneumonia.
Management: There is no specific antidote. In case of accidental ingestion, do not induce vomiting. Seek immediate medical help or contact a Poison Control Center. Provide supportive and symptomatic treatment. If topical overdose occurs (e.g., excessive application), it may lead to intense skin irritation; the ointment should be thoroughly washed off with soap and water.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Rx Only
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Kagocel pills 12mg, 30pcs
Cortexin, 10mg, 5ml, 10pcs
Actovegin pills 200mg, 50pcs
Nootropil pills 800mg, 30pcs
Ingavirin capsules 90mg, 10pcs
Noopept, pills 10mg, 50pcs
No-spa pills 40mg, 64pcs
Belosalic, ointment, 30g
Belosalic, lotion solution for external use spray 100ml
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Phenibut-Vertex pills 250mg, 20pcs
Mildronate capsules 500mg, 90pcs
Fenotropil pills 100mg, 60pcs
Arbidol, capsules 100mg, 40pcs
Daivobet, ointment, 30g
OKI, sachets 80mg 2g, 12pcs
Picamilon pills 50mg, 60pcs 